Development and Performance of a Gas Chromatography-Time-of-Flight Mass Spectrometry Analysis for Large-Scale Nontargeted Metabolomic Studies of Human Serum

被引:157
作者
Begley, Paul [1 ]
Francis-McIntyre, Sue [1 ]
Dunn, Warwick B. [2 ]
Broadhurst, David I. [1 ]
Halsall, Antony [1 ]
Tseng, Andy [1 ]
Knowles, Joshua [3 ]
Goodacre, Royston [2 ]
Kell, Douglas B. [1 ]
机构
[1] Univ Manchester, Manchester Interdisciplinary Bioctr, Sch Chem, Bioanalyt Sci Grp, Manchester M1 7DN, Lancs, England
[2] Univ Manchester, Manchester Interdisciplinary Bioctr, Sch Chem, Manchester Ctr Integrat Syst Biol, Manchester M1 7DN, Lancs, England
[3] Univ Manchester, Manchester Interdisciplinary Bioctr, Sch Comp Sci, Manchester M1 7DN, Lancs, England
基金
英国工程与自然科学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
LIQUID-CHROMATOGRAPHY; METABONOMIC ANALYSIS; PLASMA; URINE; SPECTROSCOPY; STRATEGIES; PATTERNS; PLATFORM; REVEALS; FUTURE;
D O I
10.1021/ac9011599
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A method for the preparation and GC-TOF-MS analysis of human serum samples has been developed and evaluated for application in long-term metabolomic studies. Serum samples were deproteinized using 3:1 methanol/serum, dried in a vacuum concentrator, and chemically derivatized in a two-stage process. Samples were analyzed by GC-TOF-MS with a 25 min analysis time. In addition, quality control (QC) samples were used to quantify process variability. Optimization of chemical derivatization was performed. Products were found to be stable for 30 h after derivatization. An assessment of within-day repeatability and within-week reproducibility demonstrates that excellent performance is observed with our developed method. Analyses were consistent over a 5 month period. Additional method testing, using spiked serum samples, showed the ability to define metabolite differences between samples from a population and samples spiked with metabolites standards. This methodology allows the continuous acquisition and application of data acquired over many months in long-term metabolomic studies, including the HUSERMET project (http://www.husermet.org/).
引用
收藏
页码:7038 / 7046
页数:9
相关论文
共 52 条
[1]  
[Anonymous], 1986, PRINCIPAL COMPONENT, DOI DOI 10.1007/978-1-4757-1904-87
[2]  
[Anonymous], 1988, Principles of Multivariate Analysis
[3]   A combined 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-α null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome [J].
Atherton, Helen J. ;
Bailey, Nigel J. ;
Zhang, Wen ;
Taylor, John ;
Major, Hilary ;
Shockcor, John ;
Clarke, Kieran ;
Griffin, Julian L. .
PHYSIOLOGICAL GENOMICS, 2006, 27 (02) :178-186
[4]   Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts [J].
Beckonert, Olaf ;
Keun, Hector C. ;
Ebbels, Timothy M. D. ;
Bundy, Jacob G. ;
Holmes, Elaine ;
Lindon, John C. ;
Nicholson, Jeremy K. .
NATURE PROTOCOLS, 2007, 2 (11) :2692-2703
[5]   Statistical strategies for avoiding false discoveries in metabolomics and related experiments [J].
Broadhurst, David I. ;
Kell, Douglas B. .
METABOLOMICS, 2006, 2 (04) :171-196
[6]   A metabolome pipeline: from concept to data to knowledge [J].
Brown, Marie ;
Dunn, Warwick B. ;
Ellis, David I. ;
Goodacre, Royston ;
Handl, Julia ;
Knowles, Joshua D. ;
O'Hagan, Steve ;
Spasic, Irena ;
Kell, Douglas B. .
METABOLOMICS, 2005, 1 (01) :39-51
[7]   Evaluation of a protocol for metabolic profiling studies on human blood plasma by combined ultra-performance liquid chromatography/mass spectrometry: From extraction to data analysis [J].
Bruce, Stephen J. ;
Jonsson, Par ;
Antti, Henrik ;
Cloarec, Olivier ;
Trygg, Johan ;
Marklund, Stefan L. ;
Moritz, Thomas .
ANALYTICAL BIOCHEMISTRY, 2008, 372 (02) :237-249
[8]   Cross-Platform Comparison of Methods for Quantitative Metabolomics of Primary Metabolism [J].
Buescher, Joerg Martin ;
Czernik, Dominika ;
Ewald, Jennifer Christina ;
Sauer, Uwe ;
Zamboni, Nicola .
ANALYTICAL CHEMISTRY, 2009, 81 (06) :2135-2143
[9]  
Centre for Drug Evaluation and Research (CDER), 2001, FDA GUID IND BIOAN M
[10]   Mass spectrometry in the clinical laboratory [J].
Chace, DH .
CHEMICAL REVIEWS, 2001, 101 (02) :445-477